JumpStart

News

JumpStart’s unpublicized (kind of) exit: MAX Endoscopy

It’s well-known among local investors that Cleveland-area economic development group JumpStart has achieved one exit (DIY Real Estate Solutions) since it began investing in Northeast Ohio startups in 2004. But what’s less known is that JumpStart had another exit of sorts last year, when a portfolio company was sold (and sold again), though it certainly […]

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

Pharma

Muscular dystrophy therapy biotech wins $250K JumpStart investment

A clinical-stage biotechnology startup that’s developing a therapy for neuromuscular diseases such as muscular dystrophy has received a $250,000 investment from nonprofit economic development group JumpStart. Cleveland-based Milo Biotechnology’s drug candidate is based on technology developed at Columbus’ Nationwide Children’s Hospital, and the company has already begun a clinical trial there, according to a statement […]

News

Microloan fund launched to support Northeast Ohio entrepreneurs

A new $250,000 microloan fund has been launched to help Northeast Ohio entrepreneurs in need of a small and quick cash infusion. The Appleseed Micro-Loan program is designed to provide loans of up to $35,000 to businesses with fewer than 50 employees and is being overseen by the Braintree Business Development Center in Mansfield, Ohio. […]

News

Euclid Ventures: A fund that wasn’t (but someday might be)

Plans for a new, small, state-backed investment fund that would’ve been operated by Cleveland-based venture development group JumpStart were shot down earlier this year by the state’s Third Frontier program. But JumpStart and the lead investor in the fund, which would be called Euclid Ventures, haven’t given up on the fund and are exploring options […]

Health IT

CoverMyMeds raises $1M for prior authorization technology

Health IT firm CoverMyMeds has raised $1 million to continue developing its prior authorization technology. The fundraising has come over the course of about a year, with the largest investors being Cleveland venture development group JumpStart and Charles Hallberg, the founder of MemberHealth, a Solon, Ohio prescription drug coverage company that sold for $630 million […]

News

A few fireworks, a lot of supporters at JumpStart community meeting

“This machine kills fascists!” That blaring howl, made by entrepreneur Marc Canter while brandishing a laptop high over his head, was certainly the highlight from a sheer entertainment standpoint of a public “community engagement meeting” held by Cleveland venture development group JumpStart. (At the end of the meeting, Canter was escorted out by security after […]

Health IT

Fake Twitter accounts officially lame; they’re targeting investors

The well-documented phenomenon of fake Twitter accounts have been used to skewer the rich and famous from politics to business to sports to Hollywood. But you know the fake Twitter trend has jumped the shark when it's happening to little-known business incubators and largely under-the-radar seed investment funds. In recent weeks, two such Northeast Ohio groups have received the fake Twitter treatment.

News

Is the Midwest the nation’s hottest venture capital market?

Investing in health is one of the reasons some are predicting the Midwest will be one of 2011's hottest growth markets for venture capital investing. Through the first three quarters of 2010, the amount of venture money invested in Midwestern startups grew 45 percent to $818 million, according to the National Venture Capital Association. That's a higher amount than Midwestern venture investment in the full year of recession-plagued 2009.